A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Clinical trial NCT07439653 · RECRUITING

Trial details

NCT number: NCT07439653
Sponsor: TORL Biotherapeutics, LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Start date: 2026-03-31
Primary completion: 2029-03-31
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.